切片檢查設備市場規模、佔有率、成長分析、按產品、按引導技術、按應用、按最終用途、按地區：2024-2031年產業預測

2022年切片檢查設備的全球市場規模為57.9億美元，從2023年的66億美元成長到2031年的188.3億美元，在預測期間（2024-2031）預計年複合成長率為14.00。

由於癌症（尤其是乳腺癌、前列腺癌和肺癌）發病率的上升以及切片檢查技術的進步，切片檢查市場經歷顯著成長。這種手術技術對於乳糜瀉和惡性等疾病的診斷非常重要，主要由放射科醫生、外科醫生和介入性心臟病專家使用針對不同器官量身定做的專用儀器進行。 電腦斷層掃描、MRI 和超音波等影像技術的創新提高了切片檢查的精確度和微創性，導致了 3D 光學活體組織切片和 MRI 標靶切片檢查等更複雜方法的採用。這些工具的整合促進更有效的器官切片檢查，特別是肝臟、腎臟和肺臟。人們對慢性病檢測的認知不斷提高，也促進了立體定位引導切片檢查等先進技術的興起。然而，它面臨著切片檢查設備高成本以及新興地區缺乏合格醫療專業人員等挑戰，這可能會阻礙市場的進一步擴張。總體而言，隨著醫療保健專業人員在癌症和其他慢性疾病負擔日益增加的情況下尋求提高診斷準確性和改善患者治療結果，不斷發展的切片檢查技術領域提供了巨大的成長機會。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊供應
• 二次資料來源和一次資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 課題
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 價值鏈分析
• 供應鏈分析
• 專利分析
• 貿易分析
• 客戶和購買標準分析
• 技術分析
• 案例研究分析
• 價格分析

切片檢查設備市場：依產品

• 市場概況
• 液態生物檢體儀器
• 針切片檢查儀器
  • 核心切片檢查裝置
  • 核心切片穿刺針
  • 核心切片檢查槍
  • 抽吸切片穿刺針
  • 真空切片檢查裝置
  • 真空切片檢查系統
  • 真空輔助切片穿刺針
• 治療托盤
• 定位線
• 切片檢查台
• 切片檢查鉗
  • 普通切片檢查鉗
  • 熱切片檢查鉗
• 其他產品

切片檢查設備市場：依導引技術分類

• 市場概況
• 非影像引導切片檢查
• 影像引導切片檢查
  • 超音波切片檢查
  • 立體定位切片檢查
  • MRI導引切片檢查
  • 其他影像引導切片檢查技術

切片檢查設備市場：依應用分類

• 市場概況
• 肺癌
• 乳癌
• 大腸直腸癌
• 腎癌
• 攝護腺癌
• 切片檢查
• 其他用途

切片檢查設備市場：依最終用戶分類

• 市場概況
• 醫院和乳癌護理中心
• 影像診斷中心
• 學術研究所
• 其他最終用戶

切片檢查設備市場：依地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Becton, Dickinson and Company（US）
• Danaher Corporation（US）
• B. Braun Melsungen AG（Germany）
• Cardinal Health, Inc.（US）
• Hologic, Inc.（US）
• Olympus Corporation（Japan）
• Boston Scientific Corporation（US）
• Fujifilm Corporation（Japan）
• Medtronic Plc（Ireland）
• Stryker Corporation（US）
• Cook Group Incorporated（US）
• Argon Medical Devices（US）
• Inrad, Inc.（US）
• Conmed Corporation（US）
• Teleflex Incorporated（US）
• Qiagen NV（Netherlands）
• Thermo Fisher Scientific, Inc.（US）
• Summit Medical LLC（US）
• Hill-Rom Holdings, Inc.（US）
• Gallini SRL（Italy）
• Transmed7, LLC（US）
• TSK Laboratory International（Japan）
• Merit Medical Systems, Inc.（US）
• DR. Japan Co., Ltd.（Japan）
• IZI Medical Products（US）
• Planmed Oy（Finland）
• Advin Health Care（India）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Bio-Rad Laboratories, Inc.（US）
• Illumina, Inc.（US）

Global Biopsy Devices Market size was valued at USD 5.79 billion in 2022 and is poised to grow from USD 6.60 billion in 2023 to USD 18.83 billion by 2031, growing at a CAGR of 14.00% in the forecast period (2024-2031).

The biopsy market is experiencing significant growth driven by a rise in cancer prevalence-particularly in breast, prostate, and lung cancers-and advancements in biopsy technologies. This surgical technique, essential in diagnosing conditions such as coeliac disease and malignancies, is primarily performed by radiologists, surgeons, and interventional cardiologists using specialized instruments tailored to various organs. Innovations in imaging technologies, including CT scans, MRIs, and ultrasound, are enhancing the precision and minimal invasiveness of biopsies, leading to the adoption of more sophisticated methods like 3D optical and MRI-targeted biopsies. The integration of these tools is facilitating more efficient organ biopsies, particularly for the liver, kidneys, and lungs. Increasing awareness around chronic disease detection is also contributing to the rise of advanced techniques, such as stereotactic-guided biopsies. However, the market faces challenges, including the high costs associated with biopsy devices and a shortage of qualified healthcare professionals in developing regions, which may impede further market expansion. Overall, the evolving landscape of biopsy technologies presents significant opportunities for growth, as healthcare providers seek to improve diagnostic accuracy and patient outcomes amidst the rising burden of cancer and other chronic diseases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopsy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopsy Devices Market Segmental Analysis

Global Biopsy Devices Market is segmented on the product, guidance technique, application, end user, and region. By Product, Market is segmented into Liquid Biopsy Instruments, Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Biopsy Tables, Biopsy Forceps, and Other Products. By Guidance Technique, Market for biopsy procedures is segmented into Non-Image-Guided Biopsy and Image-Guided Biopsy techniques. By Application, market is segmented into Lung Cancer, Breast Cancer, Colorectal Cancer, Kidney Cancer, Prostate Cancer, Bone Marrow Biopsy, and Other Applications. By End User, the Market is segmented into Hospitals & Breast Care Centers, Diagnostic Imaging Centers, Academic & Research Institutes, and Other End Users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Biopsy Devices Market

The global biopsy devices market is notably propelled by the alarming rise in cancer incidence across various demographics and regions. As cancer cases continue to escalate, the demand for accurate and early diagnostic methodologies becomes paramount for effective treatment and management. This heightened awareness of early detection is fostering a significant uptick in biopsy procedures, thus driving innovation and advancements in biopsy technologies. The market is witnessing a surge in the development of sophisticated biopsy devices designed to enhance precision, reduce patient discomfort, and improve diagnostic outcomes, ultimately shaping a robust landscape for future growth in the biopsy devices sector.

Restraints in the Global Biopsy Devices Market

The Global Biopsy Devices market faces a significant restraint in the form of limited access to advanced biopsy technologies, particularly in developing regions. Economic constraints and underdeveloped healthcare infrastructure inhibit the availability and adoption of state-of-the-art biopsy instruments, resulting in a disparity in healthcare quality. This restricted access not only curtails market penetration but also impacts patient outcomes, as many individuals in these regions may remain undiagnosed or receive suboptimal care. Consequently, this gap in accessibility poses a challenge to market expansion and innovation, stifling the potential growth of biopsy device manufacturers looking to enter diverse global markets.

Market Trends of the Global Biopsy Devices Market

The Global Biopsy Devices market is experiencing a significant trend towards the adoption of image-guided biopsy techniques, driven by advancements in imaging technologies such as ultrasound and CT scan guidance. These techniques offer real-time imaging capabilities that enhance the precision and accuracy of biopsy procedures, resulting in improved patient outcomes and diagnostic accuracy. As healthcare providers increasingly prioritize minimally invasive methods and precise interventions, the demand for sophisticated biopsy devices has surged. This growing preference for image-guided approaches is set to propel market growth, reflecting a broader shift towards innovation and technology-driven solutions in the medical field.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Supply Chain Analysis
• Patent Analysis
• Trade Analysis
• Customer & Buying Criteria Analysis
• Technology Analysis
• Case Study Analysis
• Pricing Analysis

Biopsy Devices Market, By Product

• Market Overview
• Liquid Biopsy Instruments
• Needle-Based Biopsy Instruments
  • Core Biopsy Devices
  • Core Biopsy Needles
  • Core Biopsy Guns
  • Aspiration Biopsy Needles
  • Vacuum-Assisted Biopsy Devices
  • Vacuum-Assisted Biopsy Systems
  • Vacuum-Assisted Biopsy Needles
• Procedure Trays
• Localization Wires
• Biopsy Tables
• Biopsy Forceps
  • General Biopsy Forceps
  • Hot Biopsy Forceps
• Other Products

Biopsy Devices Market, By Guidance Technique

• Market Overview
• Non-Image-Guided Biopsy
• Image-Guided Biopsy
  • Ultrasound-Guided Biopsy
  • Stereotactic-Guided Biopsy
  • Mri-Guided Biopsy
  • Other Image-Guided Biopsy Techniques

Biopsy Devices Market, By Application

• Market Overview
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Kidney Cancer
• Prostate Cancer
• Bone Marrow Biopsy
• Other Applications

Biopsy Devices Market, By End User

• Market Overview
• Hospitals & Breast Care Centers
• Diagnostic Imaging Centers
• Academic & Research Institutes
• Other End Users

Biopsy Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Group Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Argon Medical Devices (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inrad, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Conmed Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Summit Medical LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hill-Rom Holdings, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gallini S.R.L (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transmed7, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TSK Laboratory International (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DR. Japan Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IZI Medical Products (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Planmed Oy (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advin Health Care (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments